BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6251359)

  • 1. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
    Nemecek GM; Wells JN; Butcher RW
    Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 5. Relaxant effects of various xanthine derivatives. Relationship to cyclic nucleotide phosphodiesterase inhibition.
    Takagi K; Ogawa K; Tanaka H; Satake T; Watanabe Y; Chijiwa T; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():353-62. PubMed ID: 1313267
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of G2 phase in unsynchronized HELA cells: synergism between adenosine 3':5'-monophosphate analogues and phosphodiesterase inhibitors.
    Kurz JB; Friedman DL
    J Cyclic Nucleotide Res; 1976; 2(6):405-15. PubMed ID: 190276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic nucleotide phosphodiesterase during exposure to WI-38 cells to prostaglandin E1.
    Nemecek GM; Ray KP; Butcher RW
    J Biol Chem; 1979 Feb; 254(3):598-601. PubMed ID: 216679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL; Garst JE; Mitchel SS; Wells JN
    Biochemistry; 1977 Jul; 16(15):3316-21. PubMed ID: 196632
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of a high molecular weight cyclic 3',5'-nucleotide phosphodiesterase isolated from rat liver.
    Rhoads AR; Olowofoyeku AK; West WL; Morris HP
    Biochem Pharmacol; 1976 Jan; 25(1):97-9. PubMed ID: 175802
    [No Abstract]   [Full Text] [Related]  

  • 12. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
    Nakagawa F; Okazaki T; Naito A; Iijima Y; Yamazaki M
    J Antibiot (Tokyo); 1985 Jul; 38(7):824-9. PubMed ID: 2993218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Szentivanyi A
    Biochem Pharmacol; 1982 Nov; 31(21):3403-6. PubMed ID: 6293511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic AMP phosphodiesterases by cyclic nucleotide analogs and nitrogen heterocycles.
    Miller JP; Sigman CC; Johnson HL; Novinson T; Springer RH; Senga K; O'Brien DE; Robins RK
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():277-90. PubMed ID: 6326528
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships between adenosine, cyclic nucleotides, and xanthines in asthma.
    Church MK; Featherstone RL; Cushley MJ; Mann JS; Holgate ST
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):670-5. PubMed ID: 3021833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoionic xanthine analogs as inhibitors of cyclic AMP phosphodiesterase.
    Glennon RA; Rogers ME; Bass RG; Ryan SB
    J Pharm Sci; 1978 Dec; 67(12):1762-5. PubMed ID: 214541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between intracellular cyclic AMP concentrations and the in vitro growth of macrophages.
    Inouye LK; Wharton W
    J Leukoc Biol; 1986 Jun; 39(6):657-70. PubMed ID: 2423623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Francis DL; Roy AC; Collier HO
    Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.